PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer

NCT06086457 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

436

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Neoplasms

Interventions

RADIATION: Radiation
DRUG: TP or PF regimen depended on investigator's choice.
BIOLOGICAL: PD-1 inhibitor

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]